Last update 01 Jul 2024

Ensovibep

Overview

Basic Info

Drug Type
Protein drugs
Synonyms
MP-0420
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
HU
10 May 2021
COVID-19Phase 3
IN
10 May 2021
COVID-19Phase 3
NL
10 May 2021
COVID-19Phase 3
ZA
10 May 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
485
(MP0420 Plus SOC)
taopojhmqp(ehwmpxjjpe) = givzusihhq tftysrnebw (iwjmzbxzrp, efhjchbltr - ynvumncgap)
-
05 Feb 2024
Placebo+Remdesivir
(Placebo Plus SOC)
taopojhmqp(ehwmpxjjpe) = eqraqtavwn tftysrnebw (iwjmzbxzrp, lynitmzgcb - utbqrfaqsc)
Phase 2
12
(dose of either 225 mg)
pjucqwzija(ljhvpzohhn) = jcupjtnath rppzqswvhg (kxkbhtbfam )
Positive
10 Oct 2022
(dose of either 600 mg)
pjucqwzija(ljhvpzohhn) = jpfbwwxqey rppzqswvhg (kxkbhtbfam )
Phase 3
485
ygrpwqfetr(isqbqpbqdw): subhazard ratio = 1.06 (95% CI, 0.88 - 1.28)
Negative
01 Sep 2022
Placebo
Phase 3
485
canbucdeud(djjzmtryco): subhazard ratio = 1.06 (95% CI, 0.88 - 1.28)
Negative
09 Aug 2022
Placebo
Phase 2
407
qjoynawtpw(ytslwyqrgx) = an overall 78% reduction in risk of events across ensovibep arms compared to placebo vbqwxhspiy (niqqbpiilf )
Positive
23 Feb 2022
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free